News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
497,244 Results
Type
Article (28631)
Company Profile (213)
Press Release (468400)
Section
Business (146231)
Career Advice (985)
Deals (25558)
Drug Delivery (65)
Drug Development (58638)
Employer Resources (100)
FDA (12515)
Job Trends (10882)
News (244658)
Policy (19893)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (3)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2034)
Academic (1)
Accelerated approval (2)
Adcomms (8)
Allergies (64)
Alliances (42270)
ALS (55)
Alzheimer's disease (1005)
Antibody-drug conjugate (ADC) (127)
Approvals (12520)
Artificial intelligence (223)
Autoimmune disease (10)
Automation (11)
Bankruptcy (181)
Best Places to Work (9017)
BIOSECURE Act (12)
Biosimilars (59)
Biotechnology (157)
Bladder cancer (42)
Brain cancer (15)
Breast cancer (186)
Cancer (1429)
Cardiovascular disease (99)
Career advice (835)
Career pathing (18)
CAR-T (117)
Cell therapy (315)
Cervical cancer (13)
Clinical research (46888)
Collaboration (629)
Compensation (160)
Complete response letters (10)
COVID-19 (2243)
CRISPR (35)
C-suite (140)
Cystic fibrosis (65)
Data (1352)
Decentralized trials (1)
Denatured (23)
Depression (21)
Diabetes (143)
Diagnostics (5515)
Digital health (16)
Diversity (6)
Diversity, equity & inclusion (30)
Drug discovery (86)
Drug pricing (54)
Drug shortages (18)
Duchenne muscular dystrophy (43)
Earnings (51138)
Editorial (17)
Employer branding (12)
Employer resources (91)
Events (72982)
Executive appointments (466)
FDA (13228)
Featured Employer (39)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (523)
Gene editing (83)
Generative AI (23)
Gene therapy (203)
GLP-1 (427)
Government (2469)
Grass and pollen (2)
Guidances (29)
Healthcare (14084)
Huntington's disease (14)
IgA nephropathy (18)
Immunology and inflammation (76)
Indications (20)
Infectious disease (2345)
Inflammatory bowel disease (114)
Inflation Reduction Act (7)
Influenza (39)
Intellectual property (53)
Interviews (150)
IPO (11125)
IRA (27)
Job creations (2280)
Job search strategy (738)
Kidney cancer (8)
Labor market (10)
Layoffs (237)
Leadership (8)
Legal (4127)
Liver cancer (58)
Lung cancer (205)
Lymphoma (97)
Machine learning (2)
Management (32)
Manufacturing (199)
MASH (39)
Medical device (12049)
Medtech (12054)
Mergers & acquisitions (14777)
Metabolic disorders (370)
Multiple sclerosis (51)
NASH (17)
Neurodegenerative disease (51)
Neuropsychiatric disorders (8)
Neuroscience (1299)
NextGen: Class of 2025 (4816)
Non-profit (2689)
Northern California (1488)
Now hiring (15)
Obesity (191)
Opinion (130)
Ovarian cancer (48)
Pain (56)
Pancreatic cancer (49)
Parkinson's disease (82)
Partnered (13)
Patents (132)
Patient recruitment (59)
Peanut (39)
People (43647)
Pharmaceutical (40)
Pharmacy benefit managers (9)
Phase I (14912)
Phase II (20489)
Phase III (15766)
Pipeline (607)
Podcasts (55)
Policy (62)
Postmarket research (1672)
Preclinical (6286)
Press Release (70)
Prostate cancer (61)
Psychedelics (12)
Radiopharmaceuticals (210)
Rare diseases (223)
Real estate (4370)
Recruiting (39)
Regulatory (14528)
Reports (24)
Research institute (1903)
Resumes & cover letters (143)
Rett syndrome (2)
RNA editing (1)
RSV (37)
Schizophrenia (36)
Series A (106)
Series B (59)
Service/supplier (10)
Sickle cell disease (32)
Southern California (1338)
Special edition (4)
Sponsored (20)
Startups (3074)
State (2)
Stomach cancer (10)
Supply chain (35)
The Weekly (31)
United States (14030)
Vaccines (564)
Venture capitalists (24)
Webinars (10)
Weight loss (107)
Women's health (23)
Worklife (8)
Date
Today (142)
Last 7 days (591)
Last 30 days (2111)
Last 365 days (25740)
2025 (4149)
2024 (26375)
2023 (30478)
2022 (40653)
2021 (43675)
2020 (41283)
2019 (34963)
2018 (26522)
2017 (25479)
2016 (24559)
2015 (28480)
2014 (21090)
2013 (17154)
2012 (18714)
2011 (19052)
2010 (17280)
Location
Africa (499)
Alabama (40)
Alaska (7)
Arizona (133)
Arkansas (9)
Asia (31872)
Australia (5400)
California (3448)
Canada (1176)
China (338)
Colorado (162)
Connecticut (161)
Delaware (84)
Europe (76513)
Florida (510)
Georgia (141)
Idaho (38)
Illinois (325)
India (15)
Indiana (190)
Iowa (6)
Japan (116)
Kansas (84)
Kentucky (12)
Louisiana (6)
Maine (24)
Maryland (530)
Massachusetts (3129)
Michigan (188)
Minnesota (263)
Mississippi (2)
Missouri (55)
Montana (26)
Nebraska (19)
Nevada (37)
New Hampshire (66)
New Jersey (1094)
New Mexico (18)
New York (1030)
North Carolina (611)
North Dakota (7)
Northern California (1488)
Ohio (117)
Oklahoma (13)
Oregon (21)
Pennsylvania (690)
Puerto Rico (5)
Rhode Island (19)
South America (747)
South Carolina (13)
South Dakota (1)
Southern California (1338)
Tennessee (60)
Texas (483)
Utah (102)
Virginia (75)
Washington D.C. (16)
Washington State (407)
West Virginia (3)
Wisconsin (38)
497,244 Results for "cambridge antibody technology group plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Hemogenyx Pharmaceuticals PLC Announces Operations Update - June 17, 2024
Hemogenyx Pharmaceuticals plc, the clinical stage biopharmaceutical group developing treatments for cancers and viral diseases, is pleased to provide an update on its ongoing activities and progress.
June 17, 2024
·
4 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
Vaccines
Bavarian Nordic’s Jynneos Elicits ‘Robust’ Mpox Antibody Response in Adolescents: Study
The mpox vaccine induced an antibody response in adolescents aged 12 to 17 years that matched that in adults, suggesting the shot can be used to protect the highly susceptible group.
October 17, 2024
·
2 min read
·
Tristan Manalac
Podcast
Examining Gene Therapies, Bispecific Antibodies and Other Novel Modalities
At the 2025 National Biotechnology Conference, gene therapies, bispecific antibodies and other novel modalities—relative newcomers to medicine—will be much discussed. In this curtain raiser,
BioSpace
speaks with conference chair Prathap Nagaraja Shastri of J&J about these highly anticipated topics.
February 25, 2025
·
1 min read
·
Jef Akst
Press Releases
DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development
February 13, 2025
·
1 min read
Collaboration
Boehringer Ingelheim Expands Cancer Pipeline With Back-to-Back Antibody Deals
On Thursday, Boehringer Ingelheim announced a partnership with Synaffix to advance antibody-drug conjugates and exercised its fourth license option under a 2013 collaboration with Oxford BioTherapeutics.
January 10, 2025
·
2 min read
·
Tristan Manalac
Deals
30 Technology’s Clinically Validated Antimicrobial Nitric Oxide Platform Acquired by Convatec Group Plc for Several Applications
30 Technology, the world leader in clinical nitric oxide generation technology for health care, announced that it has completed the sale of its antimicrobial nitric oxide platform in certain applications to Convatec Group Plc.
April 19, 2023
·
6 min read
Press Releases
Genflow Biosciences PLC Announces Holding(s) in Company - 1
January 13, 2025
·
3 min read
Press Releases
Angle PLC Announces Trading Update
January 23, 2025
·
3 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Placing to raise £340,000
January 8, 2025
·
3 min read
1 of 49,725
Next
